Expression of apoptotic regulatory molecules in renal cell carcinoma: Elevated expression of Fas ligand

Olive, Colleen; Cheung, Catherine; Nicol, David; Falk, Michael C; Olive
February 1999
Immunology & Cell Biology;Feb1999, Vol. 77 Issue 1, p11
Academic Journal
Renal cell carcinoma (RCC) is the most common renal neoplasm. Despite being infiltrated by tumour infiltrating lymphocytes (TIL), these TIL are unable to control tumour growth in vivo, suggesting that the cytotoxic capacity of TIL against RCC is impaired, or that the tumour cells are resistant to killing and therefore escape detection by the immune system. It is postulated that the expression of apoptotic regulatory molecules in RCC favours tumour cell survival. The present study has therefore determined the expression of Fas (APO-1/CD95), Fas ligand (Fas L) and bcl-2 in these tumours. The expression of Fas, Fas L and bcl-2 mRNA transcripts was determined in RCC, normal kidney and peripheral blood by semiquantitative reverse transcriptase polymerase chain reaction (RT-PCR), following RNA extraction and cDNA synthesis from tissues and cell samples. Transcript levels were measured by densitometry after Southern blot hybridization of PCR products with internal radio-labelled oligonucleotide probes; a densitometry score was assigned to each hybridizing DNA band and expressed as a ratio of the glyceraldehyde-3-phosphate dehydrogenase content. In peripheral blood, the expression of Fas L and bcl-2 transcripts was similar between patients and normal healthy individuals; however, Fas transcript expression was significantly down-regulated in the patients’ versus normal peripheral blood (P = 0.026). Most interestingly, significantly up-regulated Fas L expression was observed in RCC compared to normal kidney (P = 0.041). In contrast, bcl-2 transcripts were well represented in normal kidney but markedly decreased in RCC (P = 0.021). The expression of Fas transcripts in normal kidney and RCC was variable. These data demonstrate elevated expression of Fas L transcripts in RCC, but the functional relevance of this remains to be investigated.


Related Articles

  • Molecular targeted therapy in advanced renal cell carcinoma: A review of its recent past and a glimpse into the near future. Yuen, John S. P. // Indian Journal of Urology;Oct2009, Vol. 25 Issue 4, p427 

    Renal cell carcinoma (RCC) is the most lethal of all urologic malignancies. Recent translational research in RCC has led to the discovery of a new class of therapeutics that specifically target important signaling molecules critical in the pathogenesis of the disease. It is now clear that these...

  • p42.3 promotes cell proliferation and invasion in human Renal-Cell Carcinoma. Pei-Hua Li; Wen-Jia Cao; Lin-Lin Mao; Hui Huang; Jun-Nian Zheng; Dong-Sheng Pei // International Journal of Clinical & Experimental Medicine;2014, Vol. 7 Issue 12, p4959 

    p42.3 is a tumor-specific gene and found to be over-expressed in many tumor cell lines and primary tumor tissues. It plays a significant role in neoplastic transformation and tumor progression. To date, the association between p42.3 and Renal-Cell Carcinoma (RCC) has not been reported. This...

  • Targeted Therapy in the Treatment of Metastatic Renal Cell Cancer. Di Lorenzo, Giuseppe; Scagliarini, Sarah; Di Napoli, Marilena; Scognamiglio, Florinda; Rizzo, Mimma; Carteni, Giacomo // Oncology;2009 Supplement 1, Vol. 77, p122 

    The treatment of metastatic renal cell carcinoma (MRCC) has evolved from being predominantly cytokine-based to being grounded in the use of drugs targeting vascular endothelial growth factor, platelet-derived growth factor and mammalian target of rapamycin (mTOR) pathways. New agents including...

  • Techniques.  // Laboratory Investigation (00236837);Feb2012 Supplement, Vol. 92, p509 

    The article presents abstracts on techniques related to medical topics which includes "RNA from Archived FFPE Blocks A Valuable Underexploited Resource," "Analysis of Molecular Targets for Renal Cell Carcinoma," and "Effect of Decalcifi cation Agents on Nucleic Acid Quantity and Quality."

  • Transient Variations in the Serum Concentrations of Cell Adhesion Molecules Following Retroperitoneal Laparoscopic and Open Radical Nephrectomy for Localized Renal-Cell Carcinoma. Yang, Lu; Fan, Tianyong; Wei, Qiang; Cui, Xiaobo; Bu, Siyuan; Han, Ping // Journal of Endourology;Oct2012, Vol. 26 Issue 10, p1323 

    Purpose: To evaluate differences in the serum concentrations of cell adhesion molecules (CAMs) after retroperitoneal laparoscopic and conventional open radical nephrectomies for localized renal-cell carcinoma (RCC). Patients and Methods: A total of 62 patients with stage T1N0M0 RCC were...

  • Proteasome inhibition overcomes the resistance of renal cell carcinoma cells against the PPARγ ligand troglitazone. von Schwarzenberg, K.; Held, S. A. E.; Schaub, A.; Brauer, K. M.; Bringmann, A.; Brossart, P. // Cellular & Molecular Life Sciences;Apr2009, Vol. 66 Issue 7, p1295 

    In order to analyze the effects of peroxisome proliferator-activated receptor-γ (PPARγ) activation on renal cell carcinomas we utilized several cell lines that were treated with the high affinity PPARγ agonist, troglitazone. Incubation of RCC cells with troglitazone resulted in reduced...

  • Preclinical Efficacy and Safety of DC-Ad-GM-CAIX Based Vaccine Therapy. Birkhäuser, Frédéric; Pantuc, Allan; Belldegrun, Arie; Riss, Joseph // AUANews;Sep2012, Vol. 17 Issue 9, p1 

    The article discusses the preclinical efficacy and safety of DC-Ad-GM-CAIX based vaccine therapy for the treatment of advanced renal cell carcinoma (RCC). The vaccine aims to induce a specific cytotoxic T lymphocyte (CTL) response against RCC tumors in patients in whom CAIX protein is expressed....

  • Endostatin gene therapy stimulates upregulation of ICAM-1 and VCAM-1 in a metastatic renal cell carcinoma model. Chaves, K C B; Peron, J P S; Chammas, R; Turaça, L T; Pesquero, J B; Braga, M S; Foguer, K; Schor, N; Bellini, M H // Cancer Gene Therapy;Aug2012, Vol. 19 Issue 8, p558 

    One of the greatest challenges in urological oncology is renal cell carcinoma (RCC), which is the third leading cause of death in genitourinary cancers. RCCs are highly vascularized and respond positively to antiangiogenic therapy. Endostatin (ES) is a fragment of collagen XVIII that possesses...

  • Alpha4 chain laminins are widely expressed in renal cell carcinomas and have a de-adhesive function. Vainionpää, Noora; Lehto, Veli-Pekka; Tryggvason, Karl; Virtanen, Ismo // Laboratory Investigation (00236837);Aug2007, Vol. 87 Issue 8, p780 

    Laminin (Lm) α4 chain, a constituent of Lm-411 and Lm-421, is mainly localized to mesenchyme-derived tissues, and is suggested to have a role in formation and function of endothelium, transmigration of inflammatory cells through endothelium, and invasion of certain tumors. In this study, we...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics